01 Communique Provides Update on Business Developments and First Quarter Fiscal 2022 Results
01 Communique Laboratory reports its Q1 fiscal 2022 results, ending January 31, 2022, showing revenue of $189,031, down from $213,262 in 2021. The net loss increased to $207,641, compared to $112,734 the previous year. The company emphasizes global expansion, particularly through a partnership in Europe, targeting cybersecurity solutions amid rising market demands. Cash reserves at the end of the quarter stood at $881,246, expected to support ongoing development of its IronCAP technology. The firm continues to grow its Asia-Pacific subscriber base, now exceeding 3,800 corporations using its secure access solution.
- Expansion of international partnerships, enhancing global market access.
- Cash reserves of $881,246 sufficient for continued investment in development.
- Over 3,800 corporations utilizing DoMobile, indicating strong demand.
- Revenue decreased by $24,231 compared to Q1 2021.
- Net loss increased by $94,907 year-over-year, indicating growing financial strain.
- Cash operating expenses rose by $45,289, reflecting increased operational costs.
TORONTO, ON / ACCESSWIRE / March 17, 2022 / 01 Communique Laboratory Inc. (the "Company") (TSXV:ONE)(OTCQB:OONEF), one of the first-to-market, enterprise level cybersecurity providers for the quantum computing era, is pleased to report the Company's first quarter fiscal 2022 results, which ended January 31, 2022.
Andrew Cheung, CEO of 01 Communique, stated, "During the first quarter we increased our exposure internationally. As previously announced, we added a global technology partner headquartered in Paris, France which expands our exposure in Europe. We look forward to further development of our business in Europe. I am also very excited about the prospects for IronCAP™ in Asia/Pacific. These strong partnerships have essentially opened a global network of excellent opportunities. We completed the quarter with
Highlights:
In November, 2021 the Company received a notice of allowance from the United States Patent and Trademark Office ("USPTO") for its Cryptographic System and Method. The patent has now been granted #11/271,715. This is further support for the innovative nature of the IronCAP™ technology which the Company believes is superior to anything on the market today. It is designed to protect customers against the ever-evolving illegitimate and malicious means of gaining access to their data.
The net loss for the first quarter 2022 was
Revenue for the first quarter 2022 was
Cash operating expenses for first quarter 2022 were
Conference Call Reminder and Information:
01 Communique will host a live teleconference allowing for questions and answers later today at 10:00AM EST (March 17, 2022) to discuss the Company's results as well as providing an update on the business prospects for IronCAP™ and IronCAP X™.
Browser (please cut-and-paste the following link into your browser):
https://us02web.zoom.us/j/83272630612?pwd=K1ZmRGhYKy9xaVE4UUVRMzJYTUFyQT09
Passcode: ironcap22
Dial-in:
Within Canada (647) 374-4685 or (647) 558-0588
Within the USA (646) 558 8656 or (669) 900 9128
Webinar ID when prompted is 832 7263 0612
Passcode: 066489703
About 01 Communique
Established in 1992, 01 Communique (TSX-V:ONE) (OTCQB:OONEF) has always been at the forefront of technology. The Company's cyber security business unit focuses on post-quantum cybersecurity with the development of its IronCAP™ technology. IronCAP™'s cryptographic system is an advanced Goppa code-based post-quantum cryptographic technology that can be implemented on classical computer systems as we know them today while at the same time can also safeguard against attacks in the future post-quantum world of computing. The Company's IronCAP™ technology is protected in the U.S.A. by its patent #11/271/215. The Company's remote access business unit provides its customers with a suite of secure remote access services and products under its I'm InTouch and I'm OnCall product offerings. The remote access offerings are protected in the U.S.A. by its patents #6,928,479 / #6,938,076 / #8,234,701; in Canada by its patents #2,309,398 / #2,524,039 and in Japan by its patent #4,875,094. For more information, visit the Company's web site at www.ironcap.ca and www.01com.com.
Cautionary Note Regarding Forward-looking Statements.
Certain statements in this news release may constitute "forward-looking" statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. When used in this news release, such statements use such words as "may", "will", "expect", "believe", "plan", "intend", "are confident" and other similar terminology. Such statements include statements regarding the commercial success of IronCAP X™, the future of quantum computers and their impact on the Company's product offering, the functionality of the Company's products and the intended product lines for the Company's technology and the potential licensing of the Company's technology. These statements reflect current expectations regarding future events and operating performance and speak only as of the date of this news release. Forward-looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements, including, but not limited to, the factors discussed under "Risk and Uncertainties" in the Company's Management`s Discussion and Analysis document filed on SEDAR. Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release, and the Company assumes no obligation to update or revise them to reflect new events or circumstances.
Neither TSX Venture Exchange ("TSX-V") nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
INVESTOR CONTACT:
Brian Stringer
Chief Financial Officer
01 Communique
(905) 795-2888 x204
Brian.stringer@01com.com
01 Communique Laboratory Inc.
SELECTED FINANCIAL INFORMATION
Consolidated Statements of Financial Position
As at January 31, 2022 and October 31, 2021
Unaudited
31-Jan-22 | 31-Oct-21 | ||||||
Assets | |||||||
Current assets | |||||||
Cash | $ | 861,246 | $ | 994,924 | |||
Accounts receivable | 172,085 | 205,527 | |||||
Prepaid expenses and other assets | 23,504 | 31,743 | |||||
1,056,835 | 1,232,174 | ||||||
Plant and equipment | 111,977 | 125,584 | |||||
Total assets | $ | 1,168,812 | $ | 1,357,758 | |||
Liabilities and Shareholders' Deficit | |||||||
Current liabilities | |||||||
Accounts payable and accrued liabilities | $ | 165,591 | $ | 182,354 | |||
Deferred revenue | 5,634 | 6,502 | |||||
Lease liability | 44,299 | 42,532 | |||||
215,524 | 231,388 | ||||||
Non-current liabilities | |||||||
Lease liability | 54,574 | 66,915 | |||||
CEBA loan payable | 40,000 | 40,000 | |||||
Total liabilities | 310,098 | 338,303 | |||||
Shareholders' deficit | |||||||
Share capital | 43,963,582 | 43,963,582 | |||||
Contributed surplus | 5,937,197 | 5,890,297 | |||||
Warrants | 93,533 | 93,533 | |||||
Deficit | (49,135,598 | ) | (48,927,957 | ) | |||
858,714 | 1,019,455 | ||||||
Total liabilities and shareholders' deficit | $ | 1,168,812 | $ | 1,357,758 |
01 Communique Laboratory Inc.
SELECTED FINANCIAL INFORMATION
Consolidated Statements of Operations and Comprehensive Income
For the 3 month periods ended January 31, 2022 and 2021
Unaudited
three months ended | ||||||
31-Jan-22 | 31-Jan-21 | |||||
Revenue | $ | 189,031 | $ | 213,262 | ||
Expenses: | ||||||
Selling, general and administrative | 201,502 | 168,284 | ||||
Research and development | 175,549 | 137,229 | ||||
Withholding taxes | 18,389 | 20,784 | ||||
395,440 | 326,297 | |||||
Loss before other income and expense | (206,409 | ) | (113,035 | ) | ||
Interest income | (186 | ) | (576 | ) | ||
Interest expense | 1,418 | 275 | ||||
Loss for the period and comprehensive loss | $ | (207,641 | ) | $ | (112,734 | ) |
Loss per common share | ||||||
Basic | $ | (0.00 | ) | $ | (0.00 | ) |
Diluted | $ | (0.00 | ) | $ | (0.00 | ) |
Weighted average number of common shares | ||||||
Basic | 94,451,221 | 91,793,701 | ||||
Diluted | 94,451,221 | 91,793,701 |
01 Communique Laboratory Inc.
SELECTED FINANCIAL INFORMATION
Consolidated Statements of Cash Flows
Unaudited
For the 3 month periods ended January 31, 2022 and 2021
three months ended | ||||||
31-Jan-22 | 31-Jan-21 | |||||
Cash provided by (used in): | ||||||
Operating activities: | ||||||
Comprehensive loss for the period | $ | (207,641 | ) | $ | (112,734 | ) |
Adjustments to reconcile loss for the period to | ||||||
net cash flows from operating activities: | ||||||
Depreciation of property and equipment | 2,386 | 1,850 | ||||
Amortization of right-of-use asset | 11,219 | 11,061 | ||||
Stock-based compensation expense | 46,900 | 21,187 | ||||
Change in non-cash working capital | 24,030 | 57,274 | ||||
(123,106 | ) | (21,362 | ) | |||
Financing activities: | ||||||
Exercise of stock options | - | 1,750 | ||||
Exercise of debenture warrants | - | 52,000 | ||||
Proceeds from loan | - | 60,000 | ||||
Lease payments made | (10,572 | ) | (11,658 | ) | ||
(10,572 | ) | 102,092 | ||||
Investing activities: | ||||||
Purchase of property and equipment | - | (2,191 | ) | |||
- | (2,191 | ) | ||||
Increase in cash and cash equivalents | (133,678 | ) | 78,539 | |||
Cash, beginning of period | 994,924 | 962,337 | ||||
Cash, end of period | $ | 861,246 | $ | 1,040,876 |
SOURCE: 01 Communique Laboratory, Inc.
View source version on accesswire.com:
https://www.accesswire.com/693441/01-Communique-Provides-Update-on-Business-Developments-and-First-Quarter-Fiscal-2022-Results
FAQ
What were 01 Communique's Q1 2022 revenue results for stock symbol OONEF?
What was the net loss reported by 01 Communique for the first quarter of fiscal 2022?
How many corporations are using DoMobile as of Q1 2022 for OONEF?
How has 01 Communique's cash position changed in Q1 2022?